Explore the Potential with AI-Driven Innovation
This comprehensive focused library is produced on demand with state-of-the-art virtual screening and parameter assessment technology driven by Receptor.AI drug discovery platform. This approach outperforms traditional methods and provides higher-quality compounds with superior activity, selectivity and safety.
Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
Our high-tech, dedicated method is applied to construct targeted libraries for receptors.
Fig. 1. The sreening workflow of Receptor.AI
This process includes extensive molecular simulations of the receptor in its native membrane environment, along with ensemble virtual screening that accounts for its conformational mobility. In the case of dimeric or oligomeric receptors, the entire functional complex is modelled, identifying potential binding pockets on and between the subunits to encompass all possible mechanisms of action.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
P10275
UPID:
ANDR_HUMAN
Alternative names:
Dihydrotestosterone receptor; Nuclear receptor subfamily 3 group C member 4
Alternative UPACC:
P10275; A0A0B4J1T2; A2RUN2; B1AKD7; C0JKD3; C0JKD4; E7EVX6; Q9UD95
Background:
The Androgen Receptor, known as the Dihydrotestosterone Receptor or Nuclear receptor subfamily 3 group C member 4, plays a pivotal role in gene expression regulation and cellular proliferation. It acts as a ligand-activated transcription factor, modulating transcription through interaction with coactivators and corepressors.
Therapeutic significance:
Linked to conditions like Androgen Insensitivity Syndrome and Spinal and Bulbar Muscular Atrophy X-linked 1, the Androgen Receptor's dysfunction elucidates its critical role in disease. Targeting its pathway offers a promising avenue for therapeutic intervention in these genetic disorders.